Browse by UCL people
Group by: Type | Date
Number of items: 5.
Article
Cantilena, Sandra;
Gasparoli, Luca;
Pal, Deepali;
Heidenreich, Olaf;
Klusmann, Jan-Henning;
Martens, Joost HA;
Faille, Alexandre;
... de Boer, Jasper; + view all
(2022)
Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemias.
Clinical and Translational Medicine
, 12
(6)
, Article e933. 10.1002/ctm2.933.
|
|
Clesham, Katherine;
Walf-Vorderwülbecke, Vanessa;
Gasparoli, Luca;
Virely, Clemence;
Cantilena, Sandra;
Tsakaneli, Alexia;
Inglott, Sarah;
... Williams, Owen; + view all
(2022)
Identification of a c-MYB-directed therapeutic for acute myeloid leukemia.
Leukemia
10.1038/s41375-022-01554-9.
(In press).
|
 |
|
Dvorkina, M;
Nieddu, V;
Chakelam, S;
Pezzolo, A;
Cantilena, S;
Leite, AP;
Chayka, O;
... Salomoni, P; + view all
(2016)
A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma.
Clinical Cancer Research
, 22
(13)
pp. 3398-3409.
10.1158/1078-0432.CCR-15-2081.
|
|
Meier, S;
Cantilena, S;
Niklison Chirou, MV;
Anderson, J;
Hargrave, D;
Salomoni, P;
de Boer, J;
(2021)
Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation.
Cell Death & Disease
, 12
, Article 785. 10.1038/s41419-021-04078-9.
|
|
Thesis
|
Cantilena, Sandra;
(2018)
Drug induced degradation of driver proteins: A novel approach to target MLL-fusions.
Doctoral thesis (Ph.D), UCL (University College London).
|
